Survival benefit of lung transplantation for cystic fibrosis in Norway

Conclusions: The survival rate of CF patients after LTx in Norway is similar to internationally published data. LTx increases survival significantly compared to the observed survival on the waitlist and patients of intermediary risk seem to have the greatest survival benefit.

Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Pathak, S., Durheim, M. T., Finstad, P. L., Holm, A. M., Leuckfeld, I. Tags: Transplantation Source Type: research